{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:55:27Z","timestamp":1789977327264,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fondation pour la Recherche Biom\u00e9dicale (FRM)","award":["IMD20131229052"],"award-info":[{"award-number":["IMD20131229052"]}]},{"name":"French Government\u2019s Investissement d\u2019Avenir program, Laboratoire d\u2019Excellence","award":["ANR-10-LABX-62-IBEID"],"award-info":[{"award-number":["ANR-10-LABX-62-IBEID"]}]},{"name":"Universit\u00e9 Versailles\u2013St\u2010Quentin"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12916-016-0755-7","type":"journal-article","created":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T12:56:52Z","timestamp":1481288212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis"],"prefix":"10.1186","volume":"14","author":[{"given":"Anna","family":"Alari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Chaussade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Domenech De Cell\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9naig","family":"Le Fouler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Varon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulla","family":"Opatowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Guillemot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Watier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,21]]},"reference":[{"key":"755_CR1","unstructured":"World Health Organization. Pneumococcal vaccines. WHO position paper - 2012. Weekly Epidemiological Record. 2012;87(14):129\u201344. pmid:24340399."},{"key":"755_CR2","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1371\/journal.pmed.1000084","volume":"6","author":"E Sabuncu","year":"2009","unstructured":"Sabuncu E, David J, Bern\u00e8de-Bauduin C, P\u00e9pin S, Leroy M, Bo\u00eblle PY, et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med. 2009;6:2002\u20137.","journal-title":"PLoS Med."},{"key":"755_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.diagmicrobio.2009.05.009","volume":"65","author":"L Dortet","year":"2009","unstructured":"Dortet L, Ploy M-C, Poyart C, Raymond J. Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology. Diagn Microbiol Infect Dis. 2009;65:49\u201357.","journal-title":"Diagn Microbiol Infect Dis."},{"key":"755_CR4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2807\/ese.13.35.18962-en","volume":"13","author":"A Lepoutre","year":"2008","unstructured":"Lepoutre A, Varon E, Georges S, Gutmann L, L\u00e9vy-bruhl D. Infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. Euro Surveill. 2008;13:367\u201372.","journal-title":"Euro Surveill."},{"key":"755_CR5","doi-asserted-by":"publisher","first-page":"11293","DOI":"10.1038\/srep11293","volume":"5","author":"M Domenech de Cell\u00e8s","year":"2015","unstructured":"Domenech de Cell\u00e8s M, Pons-Salort M, Varon E, Vibet M-A, Ligier C, Letort V, et al. Interaction of vaccination and reduction of antibiotic use drives unexpected increase of pneumococcal meningitis. Sci Rep. 2015;5:11293.","journal-title":"Sci Rep"},{"key":"755_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131494","volume":"10","author":"M Linden van der","year":"2015","unstructured":"van der Linden M, Falkenhorst G, Perniciaro S, Im\u00f6hl M. Effects of infant pneumococcal conjugate vaccination on serotype distribution in invasive pneumococcal disease among children and adults in Germany. PLoS One. 2015;10, e0131494.","journal-title":"PLoS One."},{"key":"755_CR7","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1016\/j.vaccine.2014.07.060","volume":"32","author":"J Meichtry","year":"2014","unstructured":"Meichtry J, Born R, K\u00fcffer M, Zwahlen M, Albrich WC, Brugger SD, et al. Serotype epidemiology of invasive pneumococcal disease in Swiss adults: a nationwide population-based study. Vaccine. 2014;32:5185\u201391.","journal-title":"Vaccine."},{"key":"755_CR8","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","volume":"11","author":"E Miller","year":"2011","unstructured":"Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4\u00a0years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis. 2011;11:760\u20138.","journal-title":"Lancet Infect Dis."},{"key":"755_CR9","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1469-0691.2009.02904.x","volume":"15","author":"M Guevara","year":"2009","unstructured":"Guevara M, Barricarte A, Gil-Setas A, Garc\u00eda-Irure JJ, Beristain X, Torroba L, et al. Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain. Clin Microbiol Infect. 2009;15:1013\u20139.","journal-title":"Clin Microbiol Infect."},{"key":"755_CR10","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1056\/NEJMoa051642","volume":"14","author":"MH Kyaw","year":"2006","unstructured":"Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med. 2006;14:1455\u201363.","journal-title":"N Engl J Med."},{"key":"755_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001517","volume":"10","author":"DR Feikin","year":"2013","unstructured":"Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, et al. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med. 2013;10, e1001517.","journal-title":"PLoS Med."},{"key":"755_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1086\/648593","volume":"201","author":"T Pilishvili","year":"2010","unstructured":"Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201:32\u201341.","journal-title":"J Infect Dis."},{"issue":"18","key":"755_CR13","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa022823","volume":"348","author":"CG Whitney","year":"2009","unstructured":"Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein\u2013polysaccharide conjugate vaccine. N Engl J Med. 2009;348(18):1737\u201346.","journal-title":"N Engl J Med"},{"key":"755_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/INF.0000000000000964","volume":"35","author":"J Estrada","year":"2016","unstructured":"Estrada J, Najera M, Pounds N, Catano G, Infante AJ. Clinical and serologic response to the 23-valent polysaccharide pneumococcal vaccine in children and teens with recurrent upper respiratory tract infections and selective antibody deficiency. Pediatr Infect Dis J. 2016;35:205\u20138.","journal-title":"Pediatr Infect Dis J."},{"key":"755_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1358\/dot.2011.47.3.1556471","volume":"47","author":"AS Ginsburg","year":"2011","unstructured":"Ginsburg AS, Alderson MR. New conjugate vaccines for the prevention of pneumococcal disease in developing countries. Drugs Today. 2011;47:207\u201314.","journal-title":"Drugs Today."},{"key":"755_CR16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.vaccine.2014.11.011","volume":"33","author":"A Lepoutre","year":"2015","unstructured":"Lepoutre A, Varon E, Georges S, Dorl\u00e9ans F, Janoir C, Gutmann L, et al. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012. Vaccine. 2015;33:359\u201366.","journal-title":"Vaccine."},{"key":"755_CR17","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1086\/656333","volume":"202","author":"JA McCullers","year":"2010","unstructured":"McCullers JA, McAuley JL, Browall S, Iverson AR, Boyd KL, Henriques NB. Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis. 2010;202:1287\u201395.","journal-title":"J Infect Dis."},{"key":"755_CR18","doi-asserted-by":"publisher","first-page":"20130519","DOI":"10.1098\/rspb.2013.0519","volume":"280","author":"L Opatowski","year":"2013","unstructured":"Opatowski L, Varon E, Dupont C, Temime L, van der Werf S, Gutmann L, et al. Assessing pneumococcal meningitis association with viral respiratory infections and antibiotics: insights from statistical and mathematical models. Proc Biol Sci. 2013;280:20130519.","journal-title":"Proc Biol Sci."},{"key":"755_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069075","volume":"8","author":"A Bernier","year":"2013","unstructured":"Bernier A, Ligier C, Guillemot D, Watier L. Did Media Attention of the 2009 A(H1N1) Influenza epidemic increase outpatient antibiotic use in France?: A time-series analysis. PLoS One. 2013;8, e69075.","journal-title":"PLoS One."},{"key":"755_CR20","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1017\/S095026881500179X","volume":"144","author":"AG Chapoutot","year":"2016","unstructured":"Chapoutot AG, Dessein R, Guilluy O, Lagr\u00e9e M, Wallet F, Varon E, et al. Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of pneumococcal meningitis in children. Epidemiol Infect. 2016;144:607\u201311.","journal-title":"Epidemiol Infect."},{"key":"755_CR21","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","volume":"294","author":"CA Lexau","year":"2005","unstructured":"Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA. 2005;294:2043\u201351.","journal-title":"JAMA."},{"key":"755_CR22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1056\/NEJMoa0800836","volume":"360","author":"HE Hsu","year":"2009","unstructured":"Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009;360:244\u201356.","journal-title":"N Engl J Med."},{"issue":"3","key":"755_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","volume":"15","author":"MR Moore","year":"2015","unstructured":"Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015;15(3):301\u20139.","journal-title":"Lancet Infect Dis"},{"key":"755_CR24","doi-asserted-by":"publisher","first-page":"6232","DOI":"10.1016\/j.vaccine.2013.10.032","volume":"31","author":"A Steens","year":"2013","unstructured":"Steens A, Riise Bergsaker MA, Aaberge IS, R\u00f8nning K, Vestrheim DF. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine. 2013;31:6232\u20138.","journal-title":"Vaccine."},{"key":"755_CR25","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/cid\/ciu524","volume":"59","author":"ZB Harboe","year":"2014","unstructured":"Harboe ZB, Dalby T, Weinberger DM, Benfield T, M\u00f8lbak K, Slotved HC, et al. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality. Clin Infect Dis. 2014;59:1066\u201373.","journal-title":"Clin Infect Dis."},{"key":"755_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1128\/AAC.01813-13","volume":"58","author":"A Bernier","year":"2014","unstructured":"Bernier A, Delarocque-Astagneau E, Ligier C, Vibet M-A, Guillemot D, Watier L. Outpatient antibiotic use in France between 2000 and 2010: after the nationwide campaign, it is time to focus on the elderly. Antimicrob Agents Chemother. 2014;58:71\u20137.","journal-title":"Antimicrob Agents Chemother."},{"key":"755_CR27","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/cid\/civ368","volume":"61","author":"L Olarte","year":"2015","unstructured":"Olarte L, Barson WJ, Barson RM, Lin PL, Romero JR, Tan TQ, et al. Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in US children. Clin Infect Dis. 2015;61:767\u201375.","journal-title":"Clin Infect Dis."},{"key":"755_CR28","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1016\/j.vaccine.2010.04.020","volume":"28","author":"R Reinert","year":"2010","unstructured":"Reinert R, Jacobs MR, Kaplan SL. Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine. 2010;28:4249\u201359.","journal-title":"Vaccine."},{"key":"755_CR29","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1097\/INF.0000000000000818","volume":"34","author":"C Godot","year":"2015","unstructured":"Godot C, Levy C, Varon E, Picard C, Madhi F, Cohen R. Pneumococcal meningitis vaccine breakthroughs and failures after routine 7-valent and 13-valent pneumococcal conjugate vaccination in children in France. Pediatr Infect Dis J. 2015;34:e260\u20133.","journal-title":"Pediatr Infect Dis J."},{"key":"755_CR30","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1542\/peds.2009-1405","volume":"125","author":"KA Bryant","year":"2010","unstructured":"Bryant KA, Block SL, Baker SA, Gruber WC, Scott DA. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine. Pediatrics. 2010;125:866\u201375.","journal-title":"Pediatrics."},{"key":"755_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","volume":"15","author":"PA Waight","year":"2015","unstructured":"Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MPE, Miller E. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4\u00a0years after its introduction: an observational cohort study. Lancet Infect Dis. 2015;15:535\u201343.","journal-title":"Lancet Infect Dis."},{"key":"755_CR32","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1016\/j.vaccine.2014.03.054","volume":"32","author":"M Guevara","year":"2014","unstructured":"Guevara M, Ezpeleta C, Gil-Setas A, Torroba L, Beristain X, Aguinaga A, et al. Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001-2013. Vaccine. 2014;32:2553\u201362.","journal-title":"Vaccine."},{"key":"755_CR33","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s10096-011-1251-9","volume":"30","author":"N Grall","year":"2011","unstructured":"Grall N, Hurmic O, Al Nakib M, Longo M, Poyart C, Ploy M-C, et al. Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine. Eur J Clin Microbiol Infect Dis. 2011;30:1511\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"755_CR34","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1097\/INF.0000000000000451","volume":"33","author":"C Levy","year":"2014","unstructured":"Levy C, Varon E, Picard C, B\u00e9chet S, Martinot A, Bonacorsi S, et al. Trends of pneumococcal meningitis in children after introduction of the 13-valent pneumococcal conjugate vaccine in France. Pediatr Infect Dis J. 2014;33:1216\u201321.","journal-title":"Pediatr Infect Dis J."},{"key":"755_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1017\/S0950268809990239","volume":"138","author":"N Chiba","year":"2010","unstructured":"Chiba N, Morozumi M, Sunaoshi K, Takahashi S, Takano M, Komori T, et al. Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan. Epidemiol Infect. 2010;138:61\u20138.","journal-title":"Epidemiol Infect."},{"key":"755_CR36","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.meegid.2011.08.016","volume":"11","author":"AV Rakov","year":"2011","unstructured":"Rakov AV, Ubukata K, Robinson DA. Population structure of hyperinvasive serotype 12\u00a0F, clonal complex 218 Streptococcus pneumoniae revealed by multilocus boxB sequence typing. Infect Genet Evol. 2011;11:1929\u201339.","journal-title":"Infect Genet Evol."},{"key":"755_CR37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/cid\/ciu366","volume":"59","author":"E Schillberg","year":"2014","unstructured":"Schillberg E, Isaac M, Deng X, Peirano G, Wylie JL, Van Caeseele P, et al. Outbreak of invasive Streptococcus pneumoniae serotype 12\u00a0F among a marginalized inner-city population in Winnipeg, Canada, 2009-2011. Clin Infect Dis. 2014;59:651\u20137.","journal-title":"Clin Infect Dis."},{"key":"755_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2334-8-81","volume":"8","author":"M Antonio","year":"2008","unstructured":"Antonio M, Dada-Adegbola H, Biney E, Awine T, O\u2019Callaghan J, Pfluger V, et al. Molecular epidemiology of pneumococci obtained from Gambian children aged 2\u201329 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine. BMC Infect Dis. 2008;8:81.","journal-title":"BMC Infect Dis."},{"key":"755_CR39","doi-asserted-by":"publisher","first-page":"6178","DOI":"10.1016\/j.vaccine.2015.10.015","volume":"33","author":"E Varon","year":"2015","unstructured":"Varon E, Cohen R, B\u00e9chet S, Doit C, Levy C. Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children. Vaccine. 2015;33:6178\u201385.","journal-title":"Vaccine."},{"key":"755_CR40","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12879-015-1147-x","volume":"15","author":"M Tin Tin Htar","year":"2015","unstructured":"Tin Tin Htar M, Christopoulou D, Schmitt H-J. Pneumococcal serotype evolution in Western Europe. BMC Infect Dis. 2015;15:419.","journal-title":"BMC Infect Dis"},{"key":"755_CR41","doi-asserted-by":"publisher","first-page":"7207","DOI":"10.1016\/j.vaccine.2011.06.056","volume":"29","author":"D Cooper","year":"2011","unstructured":"Cooper D, Yu X, Sidhu M, Nahm MH, Fernsten P, Jansen KU. The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A. Vaccine. 2011;29:7207\u201311.","journal-title":"Vaccine."},{"key":"755_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090935","volume":"9","author":"C Janoir","year":"2014","unstructured":"Janoir C, Cohen R, Levy C, Bingen E, Lepoutre A, Gutmann L, et al. Clonal expansion of the macrolide resistant ST386 within pneumococcal serotype 6C in France. PLoS One. 2014;9, e90935.","journal-title":"PLoS One."},{"key":"755_CR43","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/EDE.0b013e31824f2f32","volume":"23","author":"M Lipsitch","year":"2013","unstructured":"Lipsitch M, Abdullahi O, Amour AD, Xie W, Daniel M, Tchetgen Tchetgen E, et al. Estimating rates of carriage acquisition and clearance and competitive ability for pneumococcal serotypes in Kenya with a Markov transition model. Epidemiology. 2013;23:510\u20139.","journal-title":"Epidemiology."},{"key":"755_CR44","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1086\/649872","volume":"50","author":"ZB Harboe","year":"2010","unstructured":"Harboe ZB, Benfield TL, Valentiner-Branth P, Hjuler T, Lambertsen L, Kaltoft M, et al. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis. 2010;50:329\u201337.","journal-title":"Clin Infect Dis."},{"key":"755_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029407","volume":"7","author":"MC Maher","year":"2012","unstructured":"Maher MC, Alemayehu W, Lakew T, Gaynor BD, Haug S, Cevallos V, et al. The fitness cost of antibiotic resistance in streptococcus pneumoniae: insight from the field. PLoS One. 2012;7, e29407.","journal-title":"PLoS One."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0755-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-016-0755-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0755-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T07:09:24Z","timestamp":1568617764000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-016-0755-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["755"],"URL":"https:\/\/doi.org\/10.1186\/s12916-016-0755-7","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]},"article-number":"211"}}